Meghanath Yenni/LinkedIn
Aug 4, 2026, 17:03
Meghanath Yenni: Anticoagulant Reversal in Clinical Practice
Meghanath Yenni, Consultant Physician at Medicover Hospitals, shared a post on LinkedIn:
”Anticoagulant Reversal in Clinical Practice:
As anticoagulant use continues to increase, clinicians are encountering more patients with major bleeding, intracranial hemorrhage, and urgent procedures requiring rapid reversal.
A recent 2026 New England Journal of Medicine review provides a practical, evidence-based update on the currently available antidotes and how they should be used.
- Reserve reversal agents for life-threatening or uncontrolled bleeding, or when emergency surgery cannot be delayed.
- Warfarin: Rapid reversal requires IV vitamin K plus 4-factor prothrombin complex concentrate (4F-PCC).
- Unfractionated heparin: Protamine remains the antidote of choice. It partially reverses LMWH and has no effect on fondaparinux.
- Dabigatran: Idarucizumab provides rapid, specific reversal, although delayed dabigatran rebound may occur in some patients.
- Factor Xa inhibitors (apixaban/rivaroxaban): Andexanet alfa provides targeted reversal in carefully selected patients but should be used judiciously because of thrombotic risk, cost, and limited indications. 4F-PCC remains the most widely used nonspecific alternative when andexanet is unavailable or unsuitable.
Before administering any antidote, ask four essential questions:
- Is the bleeding truly life-threatening?
- Is clinically significant anticoagulant still present?
- Can the procedure safely be delayed?
- Does the patient’s thrombotic risk outweigh the benefit of reversal?
As newer anticoagulants become increasingly common, understanding when—and when not—to reverse anticoagulation is becoming just as important as knowing which antidote to use.”
Stay updated with Hemostasis Today.
-
Aug 4, 2026, 17:14Edward Lee Carter: Not Every Stroke on a DOAC Is a DOAC Failure
-
Aug 4, 2026, 16:52Zain Tariq: TESLA One-Year Outcomes Published in JAMA
-
Aug 4, 2026, 16:31Javed Anees: When Rheumatic Heart Disease Causes Stroke
-
Aug 4, 2026, 16:15Violeta Jardin: The Missing Link in TXA Use for Postpartum Hemorrhage
-
Aug 4, 2026, 14:43Moustafa Abdou: How to Recognize and Manage Hematologic Emergencies in Time
-
Aug 4, 2026, 14:40Majd A.AbuAlrob: Is TPA Beneficial for Spinal Infarction?
-
Aug 4, 2026, 14:27What Detecting Atrial Fibrillation After Stroke Really Means for Patient Care – International Journal of Stroke
-
Aug 4, 2026, 14:19Caitlin Raymond: Unvaccinated Blood Requests and Their Impact on Patient Safety
-
Aug 4, 2026, 13:50Hamish Aitken-Buck: New Insights Challenge the Role of Histidine Rich Glycoprotein in Thrombosis